FIELD: pharmaceutics.
SUBSTANCE: invention relates to the application of a ligand compound of α7-nicotinic acetylcholine receptor as PET visualization means, where the structural formula of the specified ligand compound is represented by the formula I.
EFFECT: technical result is obtaining ligand compound of α7-nicotinic acetylcholine receptor.
1 cl, 8 dwg, 13 tbl, 19 ex
Title | Year | Author | Number |
---|---|---|---|
NICOTINIC RECEPTOR LIGANDS | 2007 |
|
RU2441007C2 |
NOVEL PRECURSORS OF GLUTAMATE DERIVATIVES | 2012 |
|
RU2600981C2 |
PHARMACEUTICAL COMPOSITION CONTAINING PYRIDONE DERIVATIVES | 2012 |
|
RU2585287C2 |
AZABICYCLIC ALKANE DERIVATIVES SUBSTITUTED WITH CONDENSED BICYCLOHETEROCYCLE | 2007 |
|
RU2437884C2 |
BENZOTHIAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION EXHIBITING PROPERTY TO BIND AMYLOID AND METHOD FOR DETECTING AMYLOID DEPOSITS IN MAMMAL | 2004 |
|
RU2440995C2 |
AZAADAMANTANE DERIVATIVES AND METHODS FOR APPLYING | 2007 |
|
RU2450002C2 |
DERIVATIVES OF HETEROARENE CARBOXAMIDE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING | 2003 |
|
RU2320656C2 |
ANTI-INFLAMMATORY COMPOUND, PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2759626C1 |
PRODUCTION OF COMPOUNDS AND COMPOSITIONS FOR SUPPRESSION OF SHP2 ACTIVITY | 2019 |
|
RU2797951C2 |
POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR | 2012 |
|
RU2604737C2 |
Authors
Dates
2021-10-04—Published
2017-06-06—Filed